Nuala Brennan

Chief Tech/Sci/R&D Officer at MOONLAKE IMMUNOTHERAPEUTICS

55 year

Health Technology

Consumer Services

Nuala Brennan active positions

Companies	Position	Start	End
MOONLAKE IMMUNOTHERAPEUTICS	Chief Tech/Sci/R&D Officer	2021-08-31	-
Moonlake Immunotherapeutics Ltd.	Chief Tech/Sci/R&D Officer	2021-08-31	-

Companies	Position	Start	End
Kymab Ltd. Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.	Chief Tech/Sci/R&D Officer	2016-03-31	2021-07-31

University of Leicester

Undergraduate Degree

International

United Kingdom	4
Switzerland	2

Operational

Chief Tech/Sci/R&D Officer	3
Undergraduate Degree	1

Sectoral

Health Technology	3
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
MOONLAKE IMMUNOTHERAPEUTICS	Health Technology

Private companies	2
Moonlake Immunotherapeutics Ltd.
Kymab Ltd. Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.	Health Technology

Private companies

Moonlake Immunotherapeutics Ltd.

Health Technology